Major trial looks at most effective speech therapy for people with Parkinson's disease.

A major clinical trial conducted by experts at the University of Nottingham has found that the Lee Silverman Voice Treatment (LSVT LOUD) is more effective than the current speech and language therapy provided by the NHS for patients with Parkinson's disease. The trial, funded by the National Institute for Health Research, involved participants from 40 NHS sites across the UK who were randomized into three groups: one receiving LSVT LOUD, one receiving NHS therapy, and one receiving no therapy. The results, published in the BMJ, showed that LSVT LOUD was more effective at reducing the impact of voice problems compared to no therapy and NHS therapy. The study highlights the importance of effective speech and language therapy for individuals with Parkinson's disease, as it can significantly improve their quality of life. [Extracted from the article]